June 24, 2025

Chasing rivals, Nuvalent to seek approval of targeted lung cancer drug – BioPharma Dive

June 24, 2025

FDA Approves Dato-DXd (Datroway) for EGFR-Positive Non-Small Cell Lung Cancer – Oncology News Central

June 24, 2025

AstraZeneca’s Datroway Gains US Approval for Advanced Lung Cancer Treatment – TipRanks

June 24, 2025

FDA Approves Datopotamab for Treatment of EGFR-Mutated Non-Small Cell Lung Cancer – Pharmacy Times

June 24, 2025

AstraZeneca/Daiichi Sankyo’s Datroway granted FDA accelerated approval for lung cancer – PMLiVE